Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps with early hair regrowth in people with alopecia areata.

FOL-005, a hair growth promoter, acts locally on mouse skin where injected and could be a promising hair loss treatment.

The project aimed to understand how genetic test results affect patients' actions and feelings in dermatology.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

The document warns against US clinics selling untested stem cell treatments without FDA approval.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

A complex of 5-aminolevulinic acid and glycyl-histidyl-lysine peptide may help increase hair count in male pattern hair loss without side effects.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

AI-09 is safe, effective, and reduces wrinkles for up to 6 months.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

A trial showed that a new treatment is safe and effective for male pattern baldness, with most participants growing new hair.

A thorough, team-based approach and clear communication improve outcomes in complex neuropsychiatric lupus cases.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Many medications may be linked to cognitive disorders, but most lack warnings on labels.

Upadacitinib improved multiple immune-related conditions in one patient.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

The collagen booster may improve healing after CO2 laser treatment for skin aging.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

AC5 improves hair loss and hair quality with high satisfaction rates.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

The treatment increased hair follicle counts and is potentially effective for male hair loss without serious side effects.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

The laser system can safely improve recovery and quality of life for cervical cancer patients after surgery.